Amphetamine Extended-Release Tablets in the Treatment of Adults With ADHD
Latest Information Update: 07 Nov 2023
At a glance
- Drugs Amfetamine (Primary)
- Indications Attention-deficit hyperactivity disorder
- Focus Registrational; Therapeutic Use
- Sponsors Tris Pharma
Most Recent Events
- 22 Jul 2022 Results published in the Tris Pharma Media Release.
- 22 Jul 2022 According to a Tris Pharma media release, study results were published in the Journal of Clinical Psychiatry.
- 20 Jul 2022 Results published in the Journal of Clinical Psychiatry